H$1QW!EKSCE!?%N.7<1$
SYSTEM PROCESSING...
H$1QW!EKSCE!?%N.7<1$
SYSTEM PROCESSING...
Posted: 2025-04-24 12:38:00 UTC
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
Status
Last Updated
2025-04-24 12:38:39 UTC
Verified By
Rollup News
Kanya Rajangam, MD, PhD, President and Chief Medical Officer of $SNTI, is looking forward to presenting data from the SENTI-202 trial at the AACR Annual Meeting on April 25-30, 2025. The data highlights the potential of SENTI-202 and Logic Gating to enhance cancer targeting while protecting healthy cells.
SENTI-202 trial data presentation at AACR Annual Meeting
Potential of SENTI-202 to treat r/r AML and for Logic Gating
Enhancing selective targeting of cancer while sparing healthy cells